The following is from The Defender. A new preprint study led by the U.S. Food and Drug Administration (FDA) has detected a potential “safety signal” for seizures and convulsions in young children after receiving the monovalent Pfizer or Moderna mRNA Covid-19 vaccines. […]
The following is an excerpt from Time. Pfizer Inc.’s vaccine to protect newborns from RSV received backing from U.S. regulatory advisers for use in pregnant mothers to protect their newborns, handing the drugmaker a win in the race to dominate
The following is an excerpt from MedPage Today. In two somewhat close votes, an FDA panel of outside experts recommended the agency approve Pfizer’s respiratory syncytial virus (RSV) vaccine for older adults, despite concerns over the potential risk for Guillain
FDA green lights new Pfizer RSV vaccine amid safety concerns Read More »
Florida’s Department of Health issued a health alert on Feb. 15 after an analysis revealed a “substantial increase” in reports to the Vaccine Adverse Event Reporting System (VAERS) from Florida following the rollout of Covid-19 vaccines. In Florida alone, there was
